Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
NCT02379793Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of calcipotriol + betamethasone in psoriasis, sponsored by LEO Pharma. Primary endpoint: Skin irritation score at 4 days. Started Mar 2015; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02379793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379793.